Closing only a half cent below yesterday's close on a very nice...

Closing only a half cent below yesterday's close on a very nice runup over the past few days isn't really bad. Once the price reached 60 cents, selling was inevitable.

You can't have a 40% plus runup in 5 trading days with no correction at all, now can you? Especially one that is entirely rumor-driven.

The real question is where this stock will be at the end of November. My guess is that it will be above 85 cents and probably knocking at the door of $1 a share.

As for the current clinical trial of AOD9604, I fully expect vindication of the results announced in 2004, but without the ambiguity that tarnished those results.